Loading…

The SARS-CoV-2 B.1.351 Variant Can Transmit in Rats But Not in Mice

Previous studies have shown that B.1.351 and other variants have extended the host range of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to mice. Sustained transmission is a prerequisite for viral maintenance in a population. However, no evidence of natural transmission of SARS-CoV-2...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in immunology 2022-04, Vol.13, p.869809-869809
Main Authors: Zhang, Cheng, Cui, Huan, Li, Entao, Guo, Zhendong, Wang, Tiecheng, Yan, Fang, Liu, Lina, Li, Yuanguo, Chen, Di, Meng, Keyin, Li, Nan, Qin, Chengfeng, Liu, Juxiang, Gao, Yuwei, Zhang, Chunmao
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Previous studies have shown that B.1.351 and other variants have extended the host range of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to mice. Sustained transmission is a prerequisite for viral maintenance in a population. However, no evidence of natural transmission of SARS-CoV-2 in wild mice has been documented to date. Here, we evaluated the replication and contact transmission of the B.1.351 variant in mice and rats. The B.1.351 variant could infect and replicate efficiently in the airways of mice and rats. Furthermore, the B.1.351 variant could not be transmitted in BALB/c or C57BL/6 mice but could be transmitted with moderate efficiency in rats by direct contact. Additionally, the B.1.351 variant did not transmit from inoculated Syrian hamsters to BALB/c mice. Moreover, the mouse-adapted SARS-CoV-2 strain C57MA14 did not transmit in mice. In summary, the risk of B.1.351 variant transmission in mice is extremely low, but the transmission risk in rats should not be neglected. We should pay more attention to the potential natural transmission of SARS-CoV-2 variants in rats and their possible spillback to humans.
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2022.869809